201 related articles for article (PubMed ID: 24950290)
1. FoxO3a nuclear localization and its association with β-catenin and Smads in IFN-α-treated hepatocellular carcinoma cell lines.
Ceballos MP; Parody JP; Quiroga AD; Casella ML; Francés DE; Larocca MC; Carnovale CE; Alvarez Mde L; Carrillo MC
J Interferon Cytokine Res; 2014 Nov; 34(11):858-69. PubMed ID: 24950290
[TBL] [Abstract][Full Text] [Related]
2. Interferon-α2b and transforming growth factor-β1 treatments on HCC cell lines: Are Wnt/β-catenin pathway and Smads signaling connected in hepatocellular carcinoma?
Ceballos MP; Parody JP; Alvarez Mde L; Ingaramo PI; Carnovale CE; Carrillo MC
Biochem Pharmacol; 2011 Dec; 82(11):1682-91. PubMed ID: 21843516
[TBL] [Abstract][Full Text] [Related]
3. FoxO3a modulation and promotion of apoptosis by interferon-α2b in rat preneoplastic liver.
Parody JP; Ceballos MP; Quiroga AD; Frances DE; Carnovale CE; Pisani GB; Alvarez ML; Carrillo MC
Liver Int; 2014 Nov; 34(10):1566-77. PubMed ID: 24289330
[TBL] [Abstract][Full Text] [Related]
4. Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1.
Dehner M; Hadjihannas M; Weiske J; Huber O; Behrens J
J Biol Chem; 2008 Jul; 283(28):19201-10. PubMed ID: 18487207
[TBL] [Abstract][Full Text] [Related]
5. Nodal enhances the activity of FoxO3a and its synergistic interaction with Smads to regulate cyclin G2 transcription in ovarian cancer cells.
Fu G; Peng C
Oncogene; 2011 Sep; 30(37):3953-66. PubMed ID: 21532621
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt.
Sunters A; Madureira PA; Pomeranz KM; Aubert M; Brosens JJ; Cook SJ; Burgering BM; Coombes RC; Lam EW
Cancer Res; 2006 Jan; 66(1):212-20. PubMed ID: 16397234
[TBL] [Abstract][Full Text] [Related]
7. Serotonin promotes the proliferation of serum-deprived hepatocellular carcinoma cells via upregulation of FOXO3a.
Liang C; Chen W; Zhi X; Ma T; Xia X; Liu H; Zhang Q; Hu Q; Zhang Y; Bai X; Liang T
Mol Cancer; 2013 Feb; 12():14. PubMed ID: 23418729
[TBL] [Abstract][Full Text] [Related]
8. Butein sensitizes HeLa cells to cisplatin through the AKT and ERK/p38 MAPK pathways by targeting FoxO3a.
Zhang L; Yang X; Li X; Li C; Zhao L; Zhou Y; Hou H
Int J Mol Med; 2015 Oct; 36(4):957-66. PubMed ID: 26310353
[TBL] [Abstract][Full Text] [Related]
9. Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells.
Li Y; Wang Z; Kong D; Murthy S; Dou QP; Sheng S; Reddy GP; Sarkar FH
J Biol Chem; 2007 Jul; 282(29):21542-50. PubMed ID: 17522055
[TBL] [Abstract][Full Text] [Related]
10. Purified vitexin compound 1 induces apoptosis through activation of FOXO3a in hepatocellular carcinoma.
Wang JG; Zheng XX; Zeng GY; Zhou YJ; Yuan H
Oncol Rep; 2014 Jan; 31(1):488-96. PubMed ID: 24247909
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of FOXO3a on Ser-7 by p38 promotes its nuclear localization in response to doxorubicin.
Ho KK; McGuire VA; Koo CY; Muir KW; de Olano N; Maifoshie E; Kelly DJ; McGovern UB; Monteiro LJ; Gomes AR; Nebreda AR; Campbell DG; Arthur JS; Lam EW
J Biol Chem; 2012 Jan; 287(2):1545-55. PubMed ID: 22128155
[TBL] [Abstract][Full Text] [Related]
12. p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine.
Zheng F; Tang Q; Wu J; Zhao S; Liang Z; Li L; Wu W; Hann S
J Exp Clin Cancer Res; 2014 Apr; 33(1):36. PubMed ID: 24766860
[TBL] [Abstract][Full Text] [Related]
13. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of FOXO3a by PI3K/Akt pathway in HK-2 renal proximal tubular epithelial cells exposed to cadmium.
Fujiki K; Inamura H; Matsuoka M
Arch Toxicol; 2013 Dec; 87(12):2119-27. PubMed ID: 23673518
[TBL] [Abstract][Full Text] [Related]
15. IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia.
Chapuis N; Park S; Leotoing L; Tamburini J; Verdier F; Bardet V; Green AS; Willems L; Agou F; Ifrah N; Dreyfus F; Bismuth G; Baud V; Lacombe C; Mayeux P; Bouscary D
Blood; 2010 Nov; 116(20):4240-50. PubMed ID: 20671123
[TBL] [Abstract][Full Text] [Related]
16. Fluid shear stress suppresses TNF-α-induced apoptosis in MC3T3-E1 cells: Involvement of ERK5-AKT-FoxO3a-Bim/FasL signaling pathways.
Bin G; Bo Z; Jing W; Jin J; Xiaoyi T; Cong C; Liping A; Jinglin M; Cuifang W; Yonggang C; Yayi X
Exp Cell Res; 2016 May; 343(2):208-217. PubMed ID: 27060196
[TBL] [Abstract][Full Text] [Related]
17. Melatonin induces transcriptional regulation of Bim by FoxO3a in HepG2 cells.
Carbajo-Pescador S; Steinmetz C; Kashyap A; Lorenz S; Mauriz JL; Heise M; Galle PR; González-Gallego J; Strand S
Br J Cancer; 2013 Feb; 108(2):442-9. PubMed ID: 23257900
[TBL] [Abstract][Full Text] [Related]
18. Purified vitexin compound 1 inhibits growth and angiogenesis through activation of FOXO3a by inactivation of Akt in hepatocellular carcinoma.
Wang J; Zheng X; Zeng G; Zhou Y; Yuan H
Int J Mol Med; 2014 Feb; 33(2):441-8. PubMed ID: 24337611
[TBL] [Abstract][Full Text] [Related]
19. Interferon alpha-induced apoptosis on rat preneoplastic liver is mediated by hepatocytic transforming growth factor beta(1).
de Luján Alvarez M; Ronco MT; Ochoa JE; Monti JA; Carnovale CE; Pisani GB; Lugano MC; Carrillo MC
Hepatology; 2004 Aug; 40(2):394-402. PubMed ID: 15368444
[TBL] [Abstract][Full Text] [Related]
20. Interferon-β gene-modified human bone marrow mesenchymal stem cells attenuate hepatocellular carcinoma through inhibiting AKT/FOXO3a pathway.
Xie C; Xie DY; Lin BL; Zhang GL; Wang PP; Peng L; Gao ZL
Br J Cancer; 2013 Sep; 109(5):1198-205. PubMed ID: 23887606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
